STOCK TITAN

Saba Capital discloses 15.88% stake in BlackRock ESG Capital (ECAT)

(Moderate)
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Saba Capital Management, L.P., Saba Capital Management GP, LLC and Boaz R. Weinstein report beneficial ownership of 15,798,219 common shares of BlackRock ESG Capital Allocation Term Trust, representing 15.88% of the outstanding common shares, in Amendment No. 37 to their Schedule 13D.

The reporting persons hold shared, and no sole, voting and dispositive power over these shares. The position was built using investor subscription proceeds, capital appreciation and ordinary-course margin borrowings, with approximately $234,847,146 paid to acquire the reported shares. Transactions between July 22 and July 31, 2026 were executed in the open market.

Positive

  • None.

Negative

  • None.

Filing Explained

The reported 15.88% stake is tied to December 31, 2025 shares outstanding, leaving its current ownership percentage unestablished.

This Amendment No. 37 is a Schedule 13D amendment, a form for ownership above 5%, and reports Saba's position through July 31, 2026; its structural consequence for existing holders is holder-level shared voting and disposition power, rather than a disclosed issuer-side transaction.

The filing states that funds and accounts advised by Saba receive the dividends and sale proceeds from the reported shares.

The reported 15.88% stake uses 99,468,307 shares outstanding as of December 31, 2025, so it is not a current denominator-based ownership measurement unless that share count remains applicable.

A later Schedule 13D amendment or issuer filing updating the Item 5 shares-outstanding figure would resolve the percentage's current basis.

Beneficial ownership 15,798,219 shares Common shares of BlackRock ESG Capital Allocation Term Trust reported by the Saba reporting group
Ownership percentage 15.88% Percentage of ECAT common shares beneficially owned, based on 99,468,307 shares outstanding as of 12/31/25
Shares outstanding baseline 99,468,307 shares ECAT common shares outstanding as of 12/31/25, from N-CSR filed 3/5/26
Aggregate acquisition cost $234,847,146 Approximate total amount paid to acquire the reported ECAT common shares
Date of event 07/31/2026 Date of the event triggering Amendment No. 37 to Schedule 13D
beneficial owner financial
"the beneficial owner of the Common Shares reported herein"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
dispositive power financial
"sole or shared power to dispose or to direct the disposition"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
margin account borrowings financial
"capital appreciation thereon and margin account borrowings made in the ordinary course"
N-CSR regulatory
"based upon 99,468,307 shares of common stock outstanding as of 12/31/25, as disclosed in the company's N-CSR filed 3/5/26"
A Form N-CSR is a regulatory filing that mutual funds and other registered investment companies send to the U.S. Securities and Exchange Commission and make available to shareholders; it includes the fund’s certified shareholder report with audited financial statements, performance data and management discussion. For investors, it’s like a fund’s official report card and financial statement combined — it helps you verify how the fund is performing, what risks and fees exist, and whether the manager’s explanations match the numbers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does Saba Capital report in BlackRock ESG Capital Allocation Term Trust (ECAT)?

Saba Capital and related reporting persons report beneficial ownership of 15,798,219 ECAT common shares, representing 15.88% of the outstanding common shares. This reflects a significant shareholder position disclosed in Amendment No. 37 to their Schedule 13D filing.

How much did Saba Capital pay to acquire its ECAT position?

The reporting group states it paid a total of approximately $234,847,146 to acquire the ECAT common shares reported. This amount reflects investor subscription proceeds, capital appreciation and ordinary-course margin borrowings used to build the position over time.

What voting and dispositive power does Saba Capital report over ECAT shares?

The reporting persons disclose 0 shares with sole voting or dispositive power and 15,798,219 shares with shared voting and shared dispositive power. This means control over the stake is exercised jointly under the described investment management structure.

What ECAT share count is used to calculate Saba Capital’s 15.88% ownership?

The 15.88% ownership figure is based on 99,468,307 ECAT common shares outstanding as of 12/31/25, as disclosed in the trust’s N-CSR filed on 3/5/26. This outstanding share number serves as the denominator for the percentage calculation.

How was Saba Capital’s ECAT stake financed according to the Schedule 13D/A?

Funds came from investor subscription proceeds, capital appreciation on those investments and margin account borrowings used in the ordinary course of business. Positions in the margin accounts, including ECAT, are pledged as collateral for any debit balances in those accounts.

What purpose does Saba Capital state for its ECAT holdings in this filing?

Under the section describing the purpose of the transaction, the filing states “Not Applicable”. The disclosure does not outline any specific plans or proposals regarding changes to ECAT’s operations, control or capital structure in connection with the reported ownership.





09262F100

(CUSIP Number)
Saba Capital Management, L.P.
405 Lexington Avenue, 58th Floor, Attention: Michael D'Angelo
New York, NY, 10174
(212) 542-4635

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
07/31/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
The percentages used herein are calculated based upon 99,468,307 shares of common stock outstanding as of 12/31/25, as disclosed in the company's N-CSR filed 3/5/26.


SCHEDULE 13D




Comment for Type of Reporting Person:
The percentages used herein are calculated based upon 99,468,307 shares of common stock outstanding as of 12/31/25, as disclosed in the company's N-CSR filed 3/5/26.


SCHEDULE 13D




Comment for Type of Reporting Person:
The percentages used herein are calculated based upon 99,468,307 shares of common stock outstanding as of 12/31/25, as disclosed in the company's N-CSR filed 3/5/26.


SCHEDULE 13D


Saba Capital Management, L.P.
Signature:/s/ Michael D'Angelo
Name/Title:General Counsel
Date:08/03/2026
Boaz R. Weinstein
Signature:/s/ Michael D'Angelo
Name/Title:Authorized Signatory
Date:08/03/2026
Saba Capital Management GP, LLC
Signature:/s/ Michael D'Angelo
Name/Title:Attorney-in-fact*
Date:08/03/2026
Comments accompanying signature:
Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823